A carregar...
Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges
Human mesenchymal stem cell (hMSC)-based therapies are of increasing interest in the field of regenerative medicine. As economic considerations have shown, allogeneic therapy seems to be the most cost-effective method. Standardized procedures based on instrumented single-use bioreactors have been sh...
Na minha lista:
| Publicado no: | Appl Microbiol Biotechnol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Springer Berlin Heidelberg
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5895685/ https://ncbi.nlm.nih.gov/pubmed/29564526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00253-018-8912-x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|